<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01582789</url>
  </required_header>
  <id_info>
    <org_study_id>EX-MKTG-37</org_study_id>
    <nct_id>NCT01582789</nct_id>
  </id_info>
  <brief_title>Comparative Study of Two Marketed Spherical Soft Contact Lenses</brief_title>
  <official_title>Clinical Evaluation of CooperVision's Avaira Spherical Daily Wear Soft Contact Lens Versus Vistakon's Oasys Spherical Daily Wear Soft Contact Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coopervision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coopervision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to obtain objective and subjective clinical data to compare the&#xD;
      performance of two soft contact lenses.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will evaluate the daily wear performance of the Avaira (enfilcon A) spherical lens&#xD;
      during two weeks of wear compared to Vistakon's Oasys (senofilcon A) spherical lens.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 9, 2012</start_date>
  <completion_date type="Actual">July 31, 2012</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comfort - First Intervention</measure>
    <time_frame>Baseline</time_frame>
    <description>Comfort - on insertion and overall assessed at baseline for first intervention on a scale 0-10. 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort - Second Intervention</measure>
    <time_frame>Baseline</time_frame>
    <description>Comfort - on insertion and overall assessed at baseline for first intervention on a scale 0-10. 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt,</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort - First Intervention</measure>
    <time_frame>2 Weeks</time_frame>
    <description>Participant response of comfort for first intervention of study lenses assessed at 2 weeks. Comfort at insertion, comfort at end of day, comfort at 2 weeks, and overall comfort were rated on subjective response scale. (Scale 0-10, 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfort - Second Intervention</measure>
    <time_frame>2 Weeks</time_frame>
    <description>Participant response of comfort for first intervention of study lenses assessed at 2 weeks. Comfort at insertion, comfort at end of day, comfort at 2 weeks, and overall comfort were rated on subjective response scale. (Scale 0-10, 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfortable Wearing Time - First Intervention</measure>
    <time_frame>2 Weeks</time_frame>
    <description>Comfortable Wearing Time. (Participant response in number of hours) Obtained at 2 weeks wear for first intervention at week two visit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comfortable Wearing Time - Second Intervention</measure>
    <time_frame>2 Weeks</time_frame>
    <description>Comfortable Wearing Time. (Participant response in number of hours) Obtained at 2 weeks wear for second intervention at week two visit.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Refractive Error</condition>
  <arm_group>
    <arm_group_label>enfilcon A/senofilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects were randomized to wear enfilcon A then Senofilcon A for two weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>senofilcon A/enfilcon A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects were randomized to wear senofilcon A then enfilcon A for two weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>enfilcon A</intervention_name>
    <description>enfilcon A daily wear soft contact lens</description>
    <arm_group_label>enfilcon A/senofilcon A</arm_group_label>
    <arm_group_label>senofilcon A/enfilcon A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>senofilcon A</intervention_name>
    <description>senofilcon A daily wear soft contact lens</description>
    <arm_group_label>enfilcon A/senofilcon A</arm_group_label>
    <arm_group_label>senofilcon A/enfilcon A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Subjects must satisfy the following conditions prior to inclusion in the study:&#xD;
&#xD;
          -  Based on his/her knowledge, must be in good general health.&#xD;
&#xD;
          -  Be 18 to 38 years old.&#xD;
&#xD;
          -  Be able and willing to adhere to the instructions set forth in this protocol and&#xD;
             complete all specified evaluation.&#xD;
&#xD;
          -  Read, indicate understanding of, and sign Written Informed Consent.&#xD;
&#xD;
          -  Be existing or successfully adapted users of soft contact lenses, but not currently&#xD;
             wearing either of the study lenses being evaluated in this trial.&#xD;
&#xD;
          -  Require a visual correction in both eyes.&#xD;
&#xD;
          -  Require a prescription between +8.00D and -12.00D and have less than -0.75D of&#xD;
             astigmatism in both eyes.&#xD;
&#xD;
          -  Achieve visual acuity of 20/25 or better in each eye with a spherical contact lens&#xD;
             prescription.&#xD;
&#xD;
          -  Must be able to wear their lenses at least 10 working days over the next 2-weeks; &gt; 8&#xD;
             hours/day assuming there are no contraindications for doing so.&#xD;
&#xD;
          -  Have normal eyes with no evidence of abnormality or disease. For the purposes of this&#xD;
             study a normal eye is defined as one having: no amblyopia; no evidence of lid&#xD;
             abnormality or infection (e.g. entropion, ectropion, chalazia, recurrent styes); no&#xD;
             clinically significant slit lamp findings (e.g. infiltrates or other slit lamp&#xD;
             findings Grade 2 or above: corneal edema, tarsal abnormalities, and conjunctival&#xD;
             injection); no other active ocular disease (e.g. glaucoma, history of recurrent&#xD;
             corneal erosions, cornea [infiltrates], conjunctiva, lids, and intraocular infection&#xD;
             or inflammation of an allergic, bacterial, or viral etiology); no aphakia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Any of the following will render a subject ineligible for inclusion:&#xD;
&#xD;
          -  Greater than 0.50D of refractive astigmatism in either eye.&#xD;
&#xD;
          -  Presbyopic or current monovision contact lens wear.&#xD;
&#xD;
          -  Cannot be currently wearing of either lenses (Avaira or Oasys)&#xD;
&#xD;
          -  Presence of clinically significant (grade 2-4) anterior segment abnormalities;&#xD;
             inflammations such as iritis; or any infection of the eye, lids, or associated&#xD;
             structures.&#xD;
&#xD;
          -  Presence of ocular or systemic disease or need of medication which might interfere&#xD;
             with contact lens wear.&#xD;
&#xD;
          -  Slit lamp findings that would contraindicate contact lens wear such as: pathological&#xD;
             dry eye or associated findings; pterygium, pinguecula or corneal scars within the&#xD;
             visual axis; neovascularization &gt; 0.75 mm in from the limbus, giant papillary&#xD;
             conjunctivitis (GPC) worse than Grade 1; anterior uveitis or iritis (past or present),&#xD;
             seborrheic eczema, seborrheic conjunctivitis, history of corneal ulcer or fungal&#xD;
             infections; poor personal hygiene&#xD;
&#xD;
          -  A known history of corneal hypoesthesia (reduced corneal sensitivity).&#xD;
&#xD;
          -  Contact lens best corrected Snellen visual acuities (VA) worse than 20/30.&#xD;
&#xD;
          -  Aphakia, Keratoconus or a highly irregular cornea&#xD;
&#xD;
        To be eligible to enter the study, subjects must have ALL of the inclusion criteria and&#xD;
        NONE of the exclusion criteria present.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Don Siegel, OD</last_name>
    <role>Study Director</role>
    <affiliation>Coopervision, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Advanced Eyecare</name>
      <address>
        <city>Pismo Beach</city>
        <state>California</state>
        <zip>93449</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eric M. White, OD, Inc.</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>April 12, 2012</study_first_submitted>
  <study_first_submitted_qc>April 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 23, 2012</study_first_posted>
  <results_first_submitted>February 25, 2016</results_first_submitted>
  <results_first_submitted_qc>March 30, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 4, 2016</results_first_posted>
  <last_update_submitted>October 5, 2020</last_update_submitted>
  <last_update_submitted_qc>October 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Refractive Errors</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Enfilcon A, Then Senofilcon A</title>
          <description>Subjects were randomized to wear enfilcon A then Senofilcon A for two weeks&#xD;
enfilcon A: enfilcon A daily wear soft contact lens&#xD;
senofilcon A: senofilcon A daily wear soft contact lens</description>
        </group>
        <group group_id="P2">
          <title>Senofilcon A, Then Enfilcon A</title>
          <description>Subjects were randomized to wear senofilcon A then enfilcon A for two weeks&#xD;
senofilcon A: senofilcon A daily wear soft contact lens&#xD;
enfilcon A: enfilcon A daily wear soft contact lens</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention (14 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention (14 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="27"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects prior to dispense of first set of study lenses</population>
      <group_list>
        <group group_id="B1">
          <title>Overall Study Group Prior to Dispense</title>
          <description>All subjects prior to dispense of first set of study lenses</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="61"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30" lower_limit="19" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comfort - First Intervention</title>
        <description>Comfort - on insertion and overall assessed at baseline for first intervention on a scale 0-10. 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt,</description>
        <time_frame>Baseline</time_frame>
        <population>one drop out at first 2 week follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Enfilcon A</title>
            <description>Subject wears enfilcon A daily wear soft contact lens as first pair</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A</title>
            <description>Subject wears senofilcon A daily wear soft contact lens as first pair</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort - First Intervention</title>
          <description>Comfort - on insertion and overall assessed at baseline for first intervention on a scale 0-10. 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt,</description>
          <population>one drop out at first 2 week follow up</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" spread="1.1"/>
                    <measurement group_id="O2" value="9.3" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.4" spread="0.9"/>
                    <measurement group_id="O2" value="9.3" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort - Second Intervention</title>
        <description>Comfort - on insertion and overall assessed at baseline for first intervention on a scale 0-10. 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt,</description>
        <time_frame>Baseline</time_frame>
        <population>one drop out at first 2 week follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Enfilcon A</title>
            <description>Subject wears enfilcon A daily wear soft contact lens as second pair</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A</title>
            <description>Subject wears senofilcon A daily wear soft contact lens as second pair</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort - Second Intervention</title>
          <description>Comfort - on insertion and overall assessed at baseline for first intervention on a scale 0-10. 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt,</description>
          <population>one drop out at first 2 week follow up</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1" spread="1.1"/>
                    <measurement group_id="O2" value="9.1" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.1" spread="1.0"/>
                    <measurement group_id="O2" value="9.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort - First Intervention</title>
        <description>Participant response of comfort for first intervention of study lenses assessed at 2 weeks. Comfort at insertion, comfort at end of day, comfort at 2 weeks, and overall comfort were rated on subjective response scale. (Scale 0-10, 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt).</description>
        <time_frame>2 Weeks</time_frame>
        <population>one drop out at first 2 week follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Enfilcon A</title>
            <description>Subject wears enfilcon A daily wear soft contact lens as first pair</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A</title>
            <description>Subject wears senofilcon A daily wear soft contact lens as first pair</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort - First Intervention</title>
          <description>Participant response of comfort for first intervention of study lenses assessed at 2 weeks. Comfort at insertion, comfort at end of day, comfort at 2 weeks, and overall comfort were rated on subjective response scale. (Scale 0-10, 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt).</description>
          <population>one drop out at first 2 week follow up</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" spread="1.8"/>
                    <measurement group_id="O2" value="8.3" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2" spread="2.1"/>
                    <measurement group_id="O2" value="7.7" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks wear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.7" spread="2.0"/>
                    <measurement group_id="O2" value="7.7" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.9" spread="1.7"/>
                    <measurement group_id="O2" value="8.2" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfort - Second Intervention</title>
        <description>Participant response of comfort for first intervention of study lenses assessed at 2 weeks. Comfort at insertion, comfort at end of day, comfort at 2 weeks, and overall comfort were rated on subjective response scale. (Scale 0-10, 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt).</description>
        <time_frame>2 Weeks</time_frame>
        <population>1 subject withdrew from study.</population>
        <group_list>
          <group group_id="O1">
            <title>Enfilcon A</title>
            <description>Subject wears enfilcon A daily wear soft contact lens as second pair</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A</title>
            <description>Subject wears senofilcon A daily wear soft contact lens as second pair</description>
          </group>
        </group_list>
        <measure>
          <title>Comfort - Second Intervention</title>
          <description>Participant response of comfort for first intervention of study lenses assessed at 2 weeks. Comfort at insertion, comfort at end of day, comfort at 2 weeks, and overall comfort were rated on subjective response scale. (Scale 0-10, 0=uncomfortable/cannot tolerate, 10=very comfortable/cannot be felt).</description>
          <population>1 subject withdrew from study.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Insertion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.5" spread="1.1"/>
                    <measurement group_id="O2" value="8.4" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>End of day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.3" spread="2.2"/>
                    <measurement group_id="O2" value="7.1" spread="2.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 weeks wear</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.4" spread="1.8"/>
                    <measurement group_id="O2" value="7.3" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Overall</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.2" spread="1.8"/>
                    <measurement group_id="O2" value="7.6" spread="2.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfortable Wearing Time - First Intervention</title>
        <description>Comfortable Wearing Time. (Participant response in number of hours) Obtained at 2 weeks wear for first intervention at week two visit.</description>
        <time_frame>2 Weeks</time_frame>
        <population>one drop out at first 2 week follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Enfilcon A</title>
            <description>Subject wears enfilcon A daily wear soft contact lens as first pair</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A</title>
            <description>Subject wears senofilcon A daily wear soft contact lens as first pair</description>
          </group>
        </group_list>
        <measure>
          <title>Comfortable Wearing Time - First Intervention</title>
          <description>Comfortable Wearing Time. (Participant response in number of hours) Obtained at 2 weeks wear for first intervention at week two visit.</description>
          <population>one drop out at first 2 week follow up</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="27"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.5" spread="3.5"/>
                    <measurement group_id="O2" value="10.7" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Comfortable Wearing Time - Second Intervention</title>
        <description>Comfortable Wearing Time. (Participant response in number of hours) Obtained at 2 weeks wear for second intervention at week two visit.</description>
        <time_frame>2 Weeks</time_frame>
        <population>one drop out at first 2 week follow up</population>
        <group_list>
          <group group_id="O1">
            <title>Enfilcon A</title>
            <description>Subject wears enfilcon A daily wear soft contact lens as second pair</description>
          </group>
          <group group_id="O2">
            <title>Senofilcon A</title>
            <description>Subject wears senofilcon A daily wear soft contact lens as second pair</description>
          </group>
        </group_list>
        <measure>
          <title>Comfortable Wearing Time - Second Intervention</title>
          <description>Comfortable Wearing Time. (Participant response in number of hours) Obtained at 2 weeks wear for second intervention at week two visit.</description>
          <population>one drop out at first 2 week follow up</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="27"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10.1" spread="3.0"/>
                    <measurement group_id="O2" value="11" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>From dispense up to 2 weeks for each intervention</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Enfilcon A/Senofilcon A</title>
          <description>enfilcon A daily wear soft contact lens 1st then cross over and subject wears the senofilcon A daily wear soft contact lens 2nd&#xD;
enfilcon A: enfilcon A daily wear soft contact lens&#xD;
senofilcon A: senofilcon A daily wear soft contact lens</description>
        </group>
        <group group_id="E2">
          <title>Senofilcon A/Enfilcon A</title>
          <description>senofilcon A daily wear soft contact lens 1st then cross over and subject wears the enfilcon A daily wear soft contact lens 2nd&#xD;
enfilcon A: enfilcon A daily wear soft contact lens&#xD;
senofilcon A: senofilcon A daily wear soft contact lens</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="27"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The investigators will not be permitted to publish or present at scientific meetings results obtained from the clinical study without prior written consent from the sponsor. Assuming that the product is marketed, it is the intention of the sponsor to publish the results of the study.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Don Siegel, OD</name_or_title>
      <organization>CooperVision, US</organization>
      <phone>623-544-3877</phone>
      <email>dsiegel@coopervision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

